Status:

COMPLETED

Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly

Lead Sponsor:

Hellenic Institute for the Study of Sepsis

Collaborating Sponsors:

Radboud University Medical Center

Conditions:

Infection

Hospitalization

Eligibility:

All Genders

65+ years

Phase:

PHASE4

Brief Summary

One small recent trial in elderly volunteers showed that BCG vaccination can protect against infectious complications, while several studies have demonstrated an increased capacity of innate immune re...

Detailed Description

In an era of antimicrobial resistance, where the already existing antimicrobials are not sufficient, the development of new strategies for the prevention and treatment of infections is of great intere...

Eligibility Criteria

Inclusion

  • Male or female
  • Age more than or equal to 65 years based on the precise date of birth
  • Discharge from hospital after hospitalization for a medical cause. All medical causes make patients eligible for enrolment with the only exception of medical causes mentioned in the exclusion criteria

Exclusion

  • Failure to obtain written informed consent
  • Solid organ malignancy or lymphoma diagnosed the last five years
  • Treatment with oral or intravenous steroids defined as daily doses of 10mg prednisone or equivalent for longer than 3 months
  • Severely immunocompromised patients. This exclusion category comprises: a) patients with known infection by the human immunodeficiency virus (HIV-1); b) neutropenic patients with less than 500 neutrophils/mm3; c) patients with solid organ transplantation; d) patients with bone marrow transplantation; e) patients under chemotherapy; f) patients with primary immunodeficiency; g) severe lymphopenia with less than 400 lymphocytes/mm3; h) treatment with any anti-cytokine therapies
  • Positive Interferon-gamma Release Assay (IGRA)

Key Trial Info

Start Date :

September 21 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2020

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03296423

Start Date

September 21 2017

End Date

November 30 2020

Last Update

January 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

4th Department of Internal Medicine, ATTIKON University Hospital

Athens, Attica, Greece, 12462